Bank of Montreal
DARE icon

Bank of Montreal’s Dare Bioscience DARE Stock Holding History

Bank of Montreal’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-167
Closed -$16K – 4166
2017
Q1 		$16K Buy
167
+166
+16,600% +$24K ﹤0.01% 3430
2016
Q4 		$0 Buy
+1
New +$95 ﹤0.01% 4070

Other funds holding DARE

PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of Montreal's DARE Position: Q2 2017 in Review

Bank of Montreal sold out of Dare Bioscience (DARE) in Q2 2017, closing a stake of 167 shares — an estimated $16K sold.

Bank of Montreal first reported a position in DARE in Q4 2016 and held it in 2 quarters. The position peaked at $16K in Q1 2017. 19 funds tracked by Wall St. Rank hold DARE as of Q2 2017.

  • Bank of Montreal reported no remaining Dare Bioscience position as of Q2 2017 after selling out during the quarter.
  • Bank of Montreal sold 167 Dare Bioscience shares in Q2 2017, an estimated $16K.
  • Bank of Montreal first reported a position in Dare Bioscience in Q4 2016 and held it in 2 quarters.
  • Bank of Montreal's Dare Bioscience position peaked at $16K in Q1 2017.
  • 19 funds tracked by Wall St. Rank held Dare Bioscience as of Q2 2017.

Based on Bank of Montreal's 13F filing for Q2 2017, filed 11 Jul 2017.